Capsules
Prostate cancer
Enza TECH
Enzalutamide Capsules
Product pack shot.
An androgen receptor inhibitor for advanced prostate cancer. The 160 mg presentation lets patients take one capsule a day instead of four.
40 mg
80 mg
160 mg
| Brand | Enza TECH |
|---|---|
| Composition | Enzalutamide Capsules |
| Dosage form | Soft gelatin capsules (40 mg) · Film-coated tablets (160 mg) |
| Strengths | 40 mg · 80 mg · 160 mg |
| Presentation | 28 capsules (40 mg) · 1 x 7 tablets (160 mg) |
| Therapeutic area | Prostate cancer |
| Category | Prescription only (Rx) |
Product information
About Enzalutamide
- Androgen receptor signalling inhibitor.
- Metastatic and non-metastatic castration-resistant prostate cancer, and metastatic castration-sensitive prostate cancer.
- Usual dose 160 mg once daily, with or without food.
- Store below 30 °C.
Related products
